OMX Nordic 40
|
2 323,24
|
-46,49
|
-1,96 %
|
Analysen zu OMX Nordic 40-Werten
| 12:41 | ABB Neutral | JP Morgan Chase & Co. | |
| 11:48 | Novo Nordisk Neutral | UBS AG | |
| 08:58 | ABB Sector Perform | RBC Capital Markets | |
| 17.11.25 | ABB Sector Perform | RBC Capital Markets | |
| 14.11.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.11.25 | AstraZeneca Outperform | Bernstein Research | |
| 12.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.11.25 | Novo Nordisk Neutral | UBS AG | |
| 11.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Novo Nordisk Halten | DZ BANK | |
| 10.11.25 | AstraZeneca Halten | DZ BANK | |
| 10.11.25 | Novo Nordisk Neutral | UBS AG | |
| 10.11.25 | AstraZeneca Outperform | Bernstein Research | |
| 10.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Nokia Buy | Deutsche Bank AG | |
| 10.11.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 10.11.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.11.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 07.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 07.11.25 | AstraZeneca Buy | UBS AG | |
| 07.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 06.11.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.25 | AstraZeneca Buy | UBS AG | |
| 06.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.11.25 | Novo Nordisk Neutral | UBS AG | |
| 06.11.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 05.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 05.11.25 | Novo Nordisk Neutral | UBS AG | |
| 05.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 04.11.25 | Nokia Buy | Jefferies & Company Inc. | |
| 31.10.25 | AstraZeneca Buy | UBS AG | |
| 31.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 31.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 29.10.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 28.10.25 | ABB Underperform | Bernstein Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.